Universal polypeptide vaccine and its application in the preparation of drugs for treating/preventing pancreatic cancer

A polypeptide vaccine and a general-purpose technology, applied in the field of general-purpose polypeptide vaccines, can solve the problem of lack of preventive measures for pancreatic cancer, and achieve the effect of reducing medical costs

Active Publication Date: 2022-05-03
HANGZHOU NEOANTIGEN THERAPEUTICS CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently, there are no effective preventive measures against pancreatic cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Universal polypeptide vaccine and its application in the preparation of drugs for treating/preventing pancreatic cancer
  • Universal polypeptide vaccine and its application in the preparation of drugs for treating/preventing pancreatic cancer
  • Universal polypeptide vaccine and its application in the preparation of drugs for treating/preventing pancreatic cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0068] A universal peptide vaccine targeting the following six mutations: KRAS-G12R; KRAS-G12V; CDKN2A-H83Y; KRAS-Q61H; TP53-R248W; CDKN2A-P94L. The polypeptide sequences for the 6 mutations are specifically as described in Table 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a universal polypeptide vaccine, which contains at least one of the following six mutations: KRAS-G12R, KRAS-G12V, CDKN2A-H83Y, KRAS-Q61H, TP53-R248W, CDKN2A-P94L. Specifically: at least one of the polypeptide sequences for the six mutations is included. The universal polypeptide vaccine can be used to prepare medicine for treating / preventing cancer (pancreatic cancer). The universal polypeptide vaccine of the invention has better immunotherapy effect on pancreatic cancer.

Description

technical field [0001] The invention relates to a universal polypeptide vaccine suitable for the treatment and prevention of pancreatic cancer. Background technique [0002] Pancreatic cancer (PAAD) is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. Its morbidity and mortality have increased significantly in recent years, and it is one of the malignant tumors with the worst prognosis. According to the latest statistics from the National Cancer Society in 2017, there were 53,670 new cases of pancreatic cancer in the United States, and 43,090 deaths. Compared with other malignant tumors, pancreatic cancer is the type of cancer with the closest new cases and death cases, which indirectly indicates the refractory nature of pancreatic cancer. On the other hand, the statistical report clearly pointed out that with the general improvement of tumor diagnosis and treatment in recent years, the survival rate of most malignant tumors has shown...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/00A61P35/00
CPCA61P35/00A61K39/0011Y02A50/30
Inventor 莫凡周秀卿林志伟陈荣昌马治明刘慧敏
Owner HANGZHOU NEOANTIGEN THERAPEUTICS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products